Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 June 2023 | Story Dr Nokuthula Tlalajoe-Mokhatla | Photo Supplied
Dr Nokuthula Tlalajoe-Mokhatla
Dr Nokuthula Tlalajoe-Mokhatla, Academic Head and Senior Lecturer at the Division of Student Learning and Development.

The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.

Dr Nokuthula Tlalajoe-Mokhatla, Academic Head and Senior Lecturer at the Division of Student Learning and Development, shares her UFS journey:

Q: Year of graduation from the UFS:

A: I graduated in 2010, 2011, 2013, and 2021 (virtual graduation).

Q: Qualification obtained from the UFS:
A: BSc Biochemistry and Microbiology, BSc Honours Biochemistry, MSc Biochemistry (Cum Laude), PhD in Health Professions Education

Q: Date of joining the UFS as a staff member:
A: I joined as an official staff member on 18 January 2016; however, I have been in the HR system since my third year (2009) when I was appointed as a Laboratory Assistant.

Q: Initial job title and current job title:

A: In the context of point 3, I would safely say I moved from Laboratory Assistant, to Demonstrator, to Lecturer, and now Academic Head of the division and Senior Lecturer.

Q: How did the UFS prepare you for the professional world?

A: Every human being can be taught a skill, be it a scientist, health professional, or accountant. However, how their soft skills complement or lack to complement the core knowledge and application will set that individual apart. That being said, I have utilised the vast opportunities that are always accessible to enhance one's development with regard to lifelong learning skills. My biggest gain was the Engaged Leadership Programme (middle management level), which I completed in 32 weeks and obtained a distinction. That type of training set me in a position that could easily have played a role in me being able to progress further in the professional world.

Q: What are your thoughts on transitioning from a UFS alumnus to a staff member?

A: The outlook is so different when you are a staff member. I am enjoying the world of being a staff member more. This is due to my struggles as a student – a story for another day. The perks and benefits are more as a staff member, and your world gets bigger and bigger. Networking with like-minded people and contributing to day-to-day activities is mind-blowing for me.

Q: Any additional comments about your experience?
A: I appreciate the support systems in our setting; it comes in handy when we doubt ourselves and think we are not enough or adequate. What I do appreciate is the opportunities that are accessible, and with the help we have in place, it brings a sense of ease to know you can equally access it.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept